Search Results - Jingwei Tian

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy by Daoyuan Chen, Xuecun Liu, Xiaoyan Lu, Jingwei Tian

Connect to this object online.

Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor by Haibo Zhu, Wenyan Wang, Chunjie Sha, Wei Guo, Chunmei Li, Fengjuan Zhao, Hongbo Wang, Wanglin Jiang, Jingwei Tian, Jingwei Tian

Connect to this object online.

LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain by Nannan Li, Chunmei Li, Rui Han, Yu Wang, Mina Yang, Hongbo Wang, Jingwei Tian

Connect to this object online.

Epigenetic Mechanism of 5-HT/NE/DA Triple Reuptake Inhibitor on Adult Depression Susceptibility in Early Stress Mice by Ping Meng, Chunmei Li, Sijin Duan, Shengmin Ji, Yangyang Xu, Yutong Mao, Hongbo Wang, Jingwei Tian

Connect to this object online.

PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo by Fangfang Li, Zongliang Liu, Heyuan Sun, Chunmei Li, Wenyan Wang, Liang Ye, Chunhong Yan, Jingwei Tian, Hongbo Wang

Connect to this object online.

Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 <i>In Vitro</i> and <i>In Vivo</i> by Min Li, Linxu Wang, Yingjie Wei, Wenyan Wang, Zongliang Liu, Aixia Zuo, Wanhui Liu, Jingwei Tian, Hongbo Wang

Connect to this object online.

PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer by Yingjie Wei, Min Li, Yuemiao Hu, Jing Lu, Lin Wang, Qikun Yin, Xuechuan Hong, Jingwei Tian, Hongbo Wang

Connect to this object online.

LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer by Jiahao Qiu, Xinfa Bai, Wenjing Zhang, Mingxu Ma, Wenyan Wang, Ye Liang, Hongbo Wang, Jingwei Tian, Pengfei Yu

Connect to this object online.

Biological evaluation and in silico studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatment by Yunjie Wang, Zhaofeng Liu, Jing Lu, Wenyan Wang, Lin Wang, Yifei Yang, Hongbo Wang, Liang Ye, Jianzhao Zhang, Jingwei Tian

Connect to this object online.

A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis by Jingwen Zhang, Guohua Yu, Yanting Yang, Yingjie Wang, Mengqi Guo, Qikun Yin, Chunhong Yan, Jingwei Tian, Fenghua Fu, Hongbo Wang

Connect to this object online.

Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo by Guangyao Lv, Dengjun Sun, Jingwen Zhang, Xiaoxia Xie, Xiaoqiong Wu, Weishuo Fang, Jingwei Tian, Chunhong Yan, Hongbo Wang, Fenghua Fu

Connect to this object online.

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist by Liang Ye, Chunmei Li, Wanglin Jiang, Yifei Yang, Wenyan Wang, Haibo Zhu, Zhengping Hu, Ning Li, Xiaobo Cen, Hongbo Wang, Jingwei Tian

Connect to this object online.

(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia by Wenyan Wang, Guangying Du, Shilan Lin, Jing Liu, Huijie Yang, Dawei Yu, Liang Ye, Fangxia Zou, Hongbo Wang, Rui Zhang, Jingwei Tian

Connect to this object online.